Lilly's orforglipron consistent with injectable GLP-1 medicines

According to an official statement from Eli Lilly and Company, "Orforglipron is the first oral small-molecule...

'Semaglutide' can be beneficial in protecting kidney function

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective...

Liraglutide increases insulin sensitivity: Study

Research published in 'Diabetes' showed that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a kind of medicine...

Higher doses of oral semaglutide improve blood sugar control

Diabetes is a chronic condition that affects one's capacity to regulate blood sugar levels. Many patients'...

Study: Common drugs for type 2 diabetes and obesity do not...

Washington [US], March 21 (ANI): Commonly used medications for type 2 diabetes and obesity called glucagon-like...

New drug combination could improve glucose, weight control in...

Washington [US], December 23 (ANI): Scientists have shown that adding an experimental cancer drug to a widely used...

Revelation of glucagon's role in diabetic heart disease

Washington D.C. [U.S.A], Feb. 22 (ANI): A new study has provided insight into glucagon's role in diabetic heart disease.